Visalytics
Visalytics
approved EB-2 (NIW)

Post-Doctoral Research Scientist

Neuroscience · Turkey · 2025-09-23

Processing Time
88 days
Decision Date
2025-09-23
Location
New Jersey
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue his research into brain microvascular mechanisms and the blood-brain barrier to identify how vascular dysfunction contributes to neurological disorders. His work focuses on developing novel therapeutic strategies and targeted drug delivery systems for conditions such as dementia, epilepsy, multiple sclerosis, and stroke. The goal is to create precision medicine interventions that overcome current limitations in drug access to the central nervous system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses neurological disorders affecting millions in the U.S., offering potential to reduce healthcare costs and improve patient outcomes.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to his robust training, 15 peer-reviewed publications, and 501 citations indicating widespread influence in neuroscience.

3 Waiver Benefit Met

On balance, the U.S. benefits from waiving the labor certification because the petitioner's unique vascular research offers breakthroughs for debilitating diseases that traditional approaches lack.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 15 peer-reviewed journal articles, 10 conference abstracts, and 501 citations, including five highly cited papers. Evidence showed his research provided the first documented evidence of a specific targeted delivery system for CNS disorders. The case satisfied all three Dhanasar prongs by demonstrating the national importance of treating neurological diseases and the petitioner's strong positioning through his academic influence.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Reference Letters Independent
Original Contributions

Similar Cases

Postdoctoral Researcher

Research and Development · Nigeria

WeGreened EB-2 (NIW) approved
Virginia 12 days 2023-02-15
The petitioner proposes to continue his research on investigating microglial-vascular interaction and cerebral blood flow regulation. This work aims to provide insight into crucial mechanisms leading to the onset of common neurological diseases to aid in the design of new therapies and treatments.
View Case

Others

Biotechnology · Iran

WeGreened EB-2 (NIW) approved
California 61 days 2024-12-12
The petitioner proposes to uncover novel neuroscientific mechanisms of brain circuitry activity to treat a wide range of neurological and developmental disorders. The work involves using high-resolution brain imaging and bioinformatics to understand disease progression and optimize early medical interventions. The research aims to connect molecular findings to practical improvements in cognitive health and personalized medicine.
View Case

Surgeon

Healthcare · Cameroon

WeGreened EB-2 (NIW) approved
Virginia 17 days 2025-02-20
The petitioner proposes to lead investigations into blood-brain barrier (BBB) integrity and develop non-invasive therapeutic strategies for neurological disorders. His work focuses on creating more effective treatments for conditions such as stroke, sepsis, glioblastoma, and Alzheimer’s disease through molecular neuroscience methodologies.
View Case

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
California 474 days 2025-03-07
The petitioner proposes to continue research into the cellular and molecular mechanisms of learning and memory to identify new therapeutic targets for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease. The work involves identifying specific neuronal dynamics and molecular mechanisms to decrease mortality and reduce national healthcare expenditures associated with neurological disorders.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Turkey

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 88 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Turkey All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist